Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist BI 456906
Author:
Affiliation:
1. Boehringer Ingelheim Pharma GmbH Biberach Germany
2. Profil Institute for Metabolic Research Neuss Germany
3. Profil Mainz GmbH & Co. KG Mainz Germany
4. Boehringer Ingelheim International GmbH Biberach Germany
Funder
Boehringer Ingelheim España
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14948
Reference55 articles.
1. Anti-obesity drug discovery: advances and challenges
2. The Obesity Epidemic — Understanding the Disease and the Treatment
3. European Commission classifies obesity as a chronic disease
4. The incretin/glucagon system as a target for pharmacotherapy of obesity;Del Prato S;Obes Rev.,2021
5. Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hepatic glucose metabolism in the steatotic liver;Nature Reviews Gastroenterology & Hepatology;2024-02-02
2. Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial;The Lancet Diabetes & Endocrinology;2024-02
3. Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond;Metabolism;2024-02
4. Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial;Diabetes, Obesity and Metabolism;2024-01-16
5. Perspectives in weight control in diabetes – Survodutide;Diabetes Research and Clinical Practice;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3